Munich, February 26, 2020: inCare, the digital therapy company, integrated its applications with the latest version of the Apple iWatch.
The latest development of inCare enables all applications, which are part of the inCare drug therapy platform, to integrate and communicate with the Apple Watch Series 5. Combined with the capability of generating a single-lead electrocardiogram this contributes to increased drug compliance in combination with direct and earlier patient engagement.
All existing inCare apps are online updated with these new features
inCare is offering digital therapies alongside pharmacological products to address improvement in personalization, adherence and behavior mediated indications.
The awarded applications are offering potential for increased drug compliance in combination with direct and earlier patient engagement by combining drugs, mobile applications, wearables and artificial intelligence technologies in a digital therapy platform for drug personalization and adherence improvement.
We are transforming care by extending digital health beyond activity monitoring and offering deeper insights about patient health patterns and medication treatment effectiveness, leading to more informed healthcare decisions and better outcomes for everyone involved.